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The mitotoxin bFGF-SAP combines the targeting specificity of basic fibrob-
last growth factor (bFGF) with the cytotoxicity of the ribosome inactivating
protein saporin (SAP) to exert a cytotoxic effect on proliferating smooth mus-
cle cells after arterial injury. Sprague-Dawley rats undervvent carotid artery
balloon injury and received an intravenous bolus of vehicle (n = 12). 5 (n =
10), 15 In = 11), or 20 (n = 10) JLg/kg bFGF-SAP at 0, 3, 6, and 9 days after
injury. Rats were euthanized at 14 days, and carotid arteries were analyzed
by computerized morphometry.
Results:
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The threshold pulse dose for reduced neointimal proliferation by bFGF-
SAP was 15 /Lgfkg with no further reduction in proliferation with 20 JL9/kg.
Reduced neointimal proliferation did not reach statistical significance with
the 5 /Lgfkg dose. When given as a continuous intravenous infusion (n =
8 ratsl at 15 /Lg/kg/day for 14-days after arterial injury (cumulative dose of
210 JLg/kgl, bFGF-SAP did not inhibit neointima formation. Arterial medial
thickness and area within the internal elastic lamina were similar in all groups.
Conclusion: Pulse dosing, but not a continuous infusion, of bFGF-SAP re-
sulted in a 46% reduction in neointimal proliferation after arterial injury. The
effect of bFGF-SAP appears to be selective for the neointima as there was
no associated medial thinning or arterial wall dilatation. Further studies op-
timizing the administration of bFGF-SAP and evaluation of its mechanism of
action will be important in utilizing this mitotoxin in the prevention of resteno-
sis.
Conclusion: Periadventitially applied polymeric fl-cyclodextrin sulfate pro-
duces sustained inhibition of intimal thickening following vascular injury, pos-
sibly by modulating cellular processes mediated by heparin binding growth
factors.
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Smooth muscle cell proliferation is critical to the pathogenesis of restenosis.
Oxygen-derived radicals are known cell mitogens. We tested whether ebse-
len, a selenium-containing heterocyclic compound with antioxidant activity
could reduce intimal thickening and increase luminal size after balloon injury
(81) in the coronary artery model. Nineteen normolipemic pigs were given
(811 of the LAD and LCX coronary arteries. At random 9 pigs were pretreated
with ebselen (2.4 g twice per day) for 3 days before 81 and continued un-
til sacrifice (2 weeks after BI). Coronary atrery sections were evaluated by
computer morphometry. The maximal intimal thickness (MIT), intimal area
(IA) luminal perimeter (LP). vessel perimeter (VP), and fracture length (FL)
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Low Molecular Weight Heparin and Hirudin
Reduce Neointimal Proliferation After Coronary
Angioplasty
Sustained Inhibition of Intimal Thickening:
Beneficial In Vitro and In Vivo Effects of
Polymeric p·Cyclodextrin Sulfate
PEG-H 3 days PEG-H 14days CLl14 days CON
1 mg/kg bolus 1 mg/kg bolus 150 Uikg bolus 100 U/kg
5 mg/kg 1xlday 5 mglkg 75 Ulkg heparin-
In ~ 11) 1xlday 2x/day bolus
In ~ 9) In ~ 8) In ~ 7)
Injury score 1.7 ± 0.4 2.2 ± 0.4 2.1±0.4 1.8 ± 0.3
Mean neointimal
thickness (mm) 0.33 ± 015 # 037±016# 039 ± 015 # 0.68 ± 0.18
Vessel wall area
(% vessel area) 47.0 ± 7.6 # 54.4 ± 9.4 # 51.5±21.4# 74 ± 113
#p < 0.02 vs CON
1903-10 I
In conclusion, a 2-hour infusion of hirulog at the time of angioplasty re-
duced angiographic restenosis as well as cross-sectional area narrowing by
plaque in this atherosclerotic rabbit model.
Conclusion: 80th CLI and PEG-H reduce neointimal proliferation after coro-
nary angioplasty, compared to standard clinical anticoagulation with a hep-
arin bolus.
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Proliferation of medial smooth muscle cells (SMC) plays a major role in
restenosis after coronary angioplasty and can be inhibited by heparin.
Platelets stimulate SMC proliferation and their aggregation post angioplasty
can be reduced by the direct thrombin inhibitor hirudin. In a porcine coro-
nary stent angioplasty model we studied the effect of 3 and 14 days treat-
ment with a novel polyethylenglycol - conjugated hirudin (PEG-H) versus
chronic low molecular weight heparin c1ivarine (CLI) versus acute unfraction-
ated heparin as a control (CON). 4 weeks post a gioplasty, hearts were periu-
sion fixed and 6 slices per angioplasty segment were analysed for neointimal
thickness and vessel wall area (% of total vessel crossectional area). Vessel
injury in each slice was assessed using a semiquantitative score (0: lamina
elastica interna intact, to 3: penetration through media). PEG-H prolonged
partial thromboplastin time to 2-2.5 x control throughout treatment period.
Results:
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Intimal thickening after vascular injury is thought to be modulated in part by
heparin binding growth factors. We hypothesized that placement of a thera-
peutic polymer in the periadventitial space capable of tightly binding growth
factors might alter the vascular response to injury. We first tested the effects
of polymeric fl-cyclodextrin sulfate (P-CDS) on smooth muscle cell (SMC)
proliferation using a quantitative protein accumulation assay. Incubation of
rat aortic SMC (2500 cells/microwell in 10% FCS, n = 96) with P-CDS was
associated with a dose dependent inhibition of proliferation. with maximum
inhibition "'50% vs. control at 1 mg/ml (p < 0.05). The proliferation assays
were repeated using media containing only recombinant basic FGF (bFGF,
5 ng/ml) which had been exposed to P-CDS (1 mg/ml) for varying periods
of time (1 min to 3 days). We demonstrated a time dependent reduction of
the bFGF mitogenic activity, with complete removal of all activity within 60
minutes. Using radiolabeled bFGF (0.25 JLg/ml), we observed rapid associ-
ation (0.23 min-1) and dissociation (7.3 x 10-5 min-1) rates, suggesting a
high affinity interaction. We then tested the effects of P-CDS on SMC mi-
gration (using a linear under-agarose assay) and demonstrated treatment of
rat aortic SMC with P-CDS (1 mg/ml) in the agar resulted in "'50% reduction
in SMC migration vs. control at 72 hours (p < 0.05). Finally, the effects of
P-CDS in vivo were studied in the rat carotid balloon injury model. SD rats
("'350 g) were randomized to periadventitial P-CDS (10 mg) or no treatment,
additional rats received treatment with unsulfated fl-cyclodextrin polymer(P-
CD). Morphometric analyses at 4 (n = 20), 14 (n = 59), and 88 days (n = 14)
demonstrated >40% reduction of intimal area and intima/media area ratios
only in the P-CDS rats. No inhibition was seen with P-CD treated rats. De-
creased bromodeoxyuridine labeled SMC (79 ± 11 vs 144 ± 23, p = 0.Q1)
were noted in the intima of P-CDS rats at 14 days. At all time points, there
were reduced total SMC counts and no reduction in % proliferation in the
intima of P-CDS rats, suggesting greater effects on SMC migration than pro-
liferation in vivo. Endothelial cell regrowth (by Evans blue staining) was in-
creased in the P-CDS rats at 14 (4.4 vs 2.2 mm, p = 0.09) and 88 days (13.0
vs 9.2 mm, p < 0.01).
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Expression of 92 kDa Gelatinase in Primary
Atherosclerotic vs Restenotic Coronary Lesions:
Evidence for Mechanical Plaque Stabilization
David L. Brown. Margaret Hibbs, Marianne Kearney, Susan Rossow, Jeffrey
M. Isner. University of California. San Diego Medical Center- San Diego. CA
Rupture of atherosclerotic plaque resulting in intravascular thrombosis and
myocardial infarction (MI). while a common sequelae of primary atheroscle-
rotic lesions. is an uncommon consequence of restenosis. We hypothesize
that the rarity of MI associated with restenotic lesions is a result of cellular
and biochemical modifications induced by the local response to balloon in-
jury rendering the site resistant to rupture (plaque stabilization). Clinical and
angiographic features of pts presenting with symptomatic primary (n = 24)
or restenotic coronary lesions (n = 12) who underwent directional atherec-
tomywere compared. Histologic analysis and immunostaining forthe matrix
degrading enzyme. 92 kDa gelatinase. were performed on each atherectomy
specimen. There was no significant difference between the 2 groups regard-
ing age, gender. incidence of diabetes. smoking. hypertension. hypercholes-
terolemia or previous MI. Extent and distribution of disease, vessel caliber
and % stenosis were not significantly different between groups. However.
8% of primary lesions were hypercellular compared to 75% (p = 0.0001) of
restenotic specimens. 92 kDa gelatinase was expressed in 79% of primary
lesions vs 0% of restenotic specimens (p = 0.0001). Thrombus was identi-
fied in 54% of primary lesions vs 22% of restenotic lesions (p < 0.05).
Conclusion: These findings suggest that, independent of clinical or angio-
graphic influences, balloon injury induced increased lesion cellularity and re-
duced expression of 92 kDa gelatinase. possibly conferring less propensity
for plaque rupture and thrombosis.
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were measured. The relation between the injury index (FLlLP) and intimal re-
sponse to injury was determined. Results: Linear regression showed good
correlation between the amount of injury (FL/LP) and IA in the control group
(r = 0.881 versus no correlation (r = 0.34) in the ebselen group. MIT was
reduced in treated pigs.
Conclusions: Ebselen improves the coronary response to BI due to a bene-
ficial effect on luminal remodeling by enhancing luminal size and by reduction
of intimal thickening.
*p < 0.03 vs control. p < 0.002 vs immed (+J. vs 4 weeks (+#). vs 12 weeks 1+#)
Remodelling of the arterial wall after balloon angioplasty (BA). and in par-
ticular extracellular matrix accumulation, remain poorly understood. To char-
acterize in-vivo collagen turnover after BA. right iliac arterial lesions were
created by an initial BA (#1) in 20 NZW normolipemic rabbits. Three weeks
later. the lesions underwent BA #2 and were sacrificed at predetermined
times (immediate. 1.4 and 12 weeks). 14C-proline (0.11 mCilkg) was infused
24 hours prior to sacrifice. The treated and contralateral control (nontreated)
iliac arteries were homogenized and extracted with 0.5 M acetic acid. The
supernatant was passed through a 30 kDa cutoff filter. which separates col-
lagen fragments from intact collagen. Newly synthesized intact collagen and
its breakdown products were measured by 14C-hydroxyproline (dpm. mean
±SD).
In 24 other rabbits. matrix metalloproteinase (MMP) activity was assessed
by gelatin zymographywhich supported the biochemical data by showing an
increase of the 72 kDa gelatinase (MMP-2) in the treated side as compared
with the control side. Both the proenzyme and activated forms of MMP-2
were evident in the treated side immediately after injury #2. peaked at 1 wk
and were detectable at 4 and 12 weeks (although at lower levels). There was
no evidence of 92 kDa gelatinase (MMP-9) activity on either side.
In conclusion. both collagen synthesis and degradation are stimulated af-
ter BA. particularly at 1 week. which may explain discrepancies between
synthesis and accumulation. A 72 kDa gelatinase is induced early following
balloon injury with a time course that parallels the pattern of collagen synthe-
sis. MMP-2 activity may represent an important mechanism of remodelling
after BA injury.
SA Control
Current Trends in Pediatric Pacing: Report of the
Midwest Pediatric Pacemaker Registry
Gerald A. Serwer. Macdonald Dick, II. Sarah LeRoy. Members of the Midwest
Pediatric Pacemaker Registry. Univ. ofMichigan, Ann Arbor- MI
The Midwest Pediatric Pacemaker Registry provides a large database from
which to characterize the current state of pediatric pacing. Currently 692
patients are registered who have had 871 generators and 944 electrodes im-
planted. Data has been grouped into two-year periods. the most recent being
information from 93-94. The most common indication for initial pacemaker
implantation in 93-94 remains surgically induced complete heart block(CHB)
accounting for 42% of initial implants. This has remained unchanged since
85-86. The most common structural lesions associated with surgical CHB
in 93-94 were atrioventricular septal defect-30%. univentricular heart-21 %,
aortic valve replacement with annular enlargement (Konno Procedure)-21 %.
Closure of ventricular septal defects were still associated with surgical CHB
(21 %), but generally only for inlet septal defects. Surgically related sick si-
nus syndrome accounted for 20% of initial implants while 35% were due to
congenital CHB. The remainder were due to non surgically induced sick si-
nus syndrome, control of tachyarrhythmias or for bradycardia secondary to
antiarrhythmic drug therapy. Dual chamber generators accounted for 42% of
generators implanted in 93-94. This is increased over prior periods. Of the
single chamber pacemakers implanted. >95% were rate responsive units.
Vet, not all were programmed to a rate variable mode. Only 55% were initially
programmed to either WIR or MIR. The percentage of transvenous implan-
tations has steadily increased reaching 42% of all implantations in 93-94.
52% of endocardial electrodes implanted used passive fixation (38% were
steroid eluting) with 38% using active fixation and 10% unknown. 68% of
endocardial electrodes were bipolar. 52% of epicardial electrodes implanted
were "fishhook" electrodes and 37% were "corkscrew" electrodes. Surgical
CHB following complex procedures continues to be the most common rea-
son for pacemaker implantation. Surgically related sick sinus syndrome has
shown a gradual increase. There has been a steady increase in the use of the
transvenous approach. dual chamber pacemakers. and rate variable pacing.
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